Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Surrozen Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SRZN
Nasdaq
8731
https://www.surrozen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Surrozen Inc
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
- Apr 3rd, 2024 12:40 pm
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
- Apr 1st, 2024 12:30 pm
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
- Apr 1st, 2024 12:30 pm
Surrozen Provides Corporate Update on Clinical Programs
- Jan 18th, 2024 1:30 pm
Surrozen Provides Third Quarter 2023 Financial Results
- Nov 8th, 2023 9:05 pm
Surrozen Provides Second Quarter 2023 Financial Results
- Aug 9th, 2023 8:05 pm
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke
- Jun 5th, 2023 12:30 pm
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates
- May 10th, 2023 8:05 pm
Scroll